Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03570619
Title Immunotherapy in Patients With Metastatic Cancers and CDK12 Mutations (IMPACT)
Acronym IMPACT
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Michigan Rogel Cancer Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of California San Diego, Moores Cancer Center San Diego California 92093 United States Details
University of California San Francisco/Helen Diller Family Comprehensive Cancer Center San Francisco California 94158 United States Details
H. Lee. Moffitt Cancer Center & Research Institute, Inc. Tampa Florida 33612 United States Details
Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore Maryland 21287 United States Details
University of Michigan Rogel Cancer Center Ann Arbor Michigan 48109 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Siteman Cancer Center at Washington University Saint Louis Missouri 63110 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field